Age- and sex-related reference values for serum insulin concentration and its biological determinants in a French healthy population. The STANISLAS cohort

References

1 Malaisse WJ. Anomalies du métabolisme insulaire dans le diabète. Med Sci 1995; 11:199–202.10.4267/10608/2186Search in Google Scholar

2 Pessin JE, Saltiel AR. Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 2000; 106:165–9.10.1172/JCI10582Search in Google Scholar

3 Steinberger J. Insulin resistance and cardiovascular risk in the pediatric patient. Prog Pediatr Cardiol 2001; 12:169–75.10.1016/S1058-9813(00)00070-9Search in Google Scholar

4 Schulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000; 106:171–6.10.1172/JCI10583Search in Google Scholar PubMed PubMed Central

5 Greenfield JR, Samaras K, Chisholm DJ. Insulin resistance, intra abdominal fat, cardiovascular risk factors, and androgens in healthy young women with type 1 diabetes mellitus. J Clin Endocrinol Metab 2002; 87:1036–40.10.1210/jcem.87.3.8324Search in Google Scholar PubMed

6 Snehalatha C, Sivasankari S, Satyavani K, Vijay V, Ramachandran A. Insulin resistance alone does not explain the clustering of cardiovascular risk factors in southern India. British Diabetic Association. Diabet Med 2000; 17:152–7.10.1046/j.1464-5491.2000.00239.xSearch in Google Scholar PubMed

7 Majores M, Kölsch H, Bagli M, Ptok U, Kochler M, Becker K, et al. The insulin gene VNTR polymorphism in Alzheimer’s disease: results of a pilot study. J Neural Transm 2002; 109:1029–34.10.1007/s007020200086Search in Google Scholar PubMed

8 Hadigan C, Rabe J, Meininger G, Aliabadi N, Breu J, Grinspoon S. Inhibition of lipolysis improves insulin sensitivity in protease inhibitor-treated HIV-infected men with fat redistribution. Am J Clin Nutr 2003; 77:490–4.10.1093/ajcn/77.2.490Search in Google Scholar PubMed

9 Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37:1595–607.10.2337/diab.37.12.1595Search in Google Scholar PubMed

10 Heald HA, Cruickshank JK, Riste LK, Cade JE, Anderson S, Greenhalgh A, et al. Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations. Diabetologia 2001; 44:333–9.10.1007/s001250051623Search in Google Scholar PubMed

11 Bell RA, Mayer-Davis EJ, Martin MA, D’Agostino RB, Haffner SM. Associations between alcohol consumption and insulin sensitivity and cardiovascular disease risk factors: the Insulin Resistance and Atherosclerosis Study. Diabetes Care 2000; 23:1630–6.10.2337/diacare.23.11.1630Search in Google Scholar

12 Ishizaka N, Ishizaka Y, Takahashi E, Unuma T, Tooda E, Nagai R, et al. Association between insulin resistance and carotid arteriosclerosis in subjects with normal fasting glucose and normal glucose intolerance. Arterioscler Thromb Vasc Biol 2003; 23:295–301.10.1161/01.ATV.0000050142.09911.0BSearch in Google Scholar

13 Morgan LM, Aspostolakou F, Wright J, Gama R. Diurnal variations in peripheral insulin resistance and plasma non-esterified fatty acid concentrations: a possible link? Ann Clin Biochem 1999; 36:447–50.10.1177/000456329903600407Search in Google Scholar

14 Sapin R, Demangeat C. Aspects analytiques des dosages d’insuline, peptide-C, proinsulines et glucagon. Nucl Med 2001; 25:73–9.Search in Google Scholar

15 Arslanian SA, Lewy VD, Danadian K. Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease. J Clin Endocrinol Metab 2001; 86:66–71.Search in Google Scholar

16 Catalano PM, Kirwan JP. Clinical utility and approaches for estimating insulin sensitivity in pregnancy. Semin Perinatol 2002; 26:181–9.10.1053/sper.2002.33977Search in Google Scholar

17 Gonzalez CG, Alonso A, Balbin M, Diaz F, Fernandez S, Patterson AM. Effects of pregnancy on insulin receptor in liver, skeletal muscle and adipose tissue of rats. Gynecol Endocrinol 2002; 16:193–205.10.1080/gye.16.3.193.205Search in Google Scholar

18 De Souza CJ, Meier AH. Circadian and seasonal variations of plasma insulin and cortisol concentrations in the Syrian hamster, Mesocricetus auratus. Chronobiol Int 1987; 4:141–51.10.3109/07420528709078520Search in Google Scholar

19 LeBlanc J, Tremblay A, Richard D, Nadeau A. Daily variations of plasma glucose and insulin in physically-trained and sedentary subjects. Metabolism 1983; 32:552–7.10.1016/0026-0495(83)90024-0Search in Google Scholar

20 Jarrousse C, Rosselin G. Interaction of amino acids and cyclic AMP on the release of insulin and glucagon by newborn rat pancreas. Endocrinology 1975; 96:168–77.10.1210/endo-96-1-168Search in Google Scholar

21 Rabe T, Runnebaum B. Update on oral contraception. Eur J Obstet Gynecol Reprod Biol 1993; 49:10–2.10.1016/0028-2243(93)90100-QSearch in Google Scholar

22 Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 2001; 293:1673–7.10.1126/science.1061620Search in Google Scholar PubMed

23 Leblanc H, Yen SS. Comparison of cyclic and linear forms of somatostatin in the inhibition of growth hormone, insulin and glucagon secretion. J Clin Endocrinol Metab 1975; 40:906–8.10.1210/jcem-40-5-906Search in Google Scholar PubMed

24 O’Moore-Sullivan TM, Prins JB. Thiazolidinediones and type 2 diabetes: new drugs for an old disease. Med J Aust 2002; 176:381–6.10.5694/j.1326-5377.2002.tb04461.xSearch in Google Scholar PubMed

25 Watson GS, Craft S. The role of insulin resistance in the pathogenesis of Alzheimer’s disease. Implications for treatment. CNS Drugs 2003; 17:27–45.10.2165/00023210-200317010-00003Search in Google Scholar PubMed

26 Kern W, Born J, Fehm HL. Role of insulin in Alzheimer’s disease: approaches emerging from basic animal research and neurocognitive studies in humans. Drug Dev Res 2002; 5:511–25.10.1002/ddr.10101Search in Google Scholar

27 Siest G, Visvikis S, Herbeth B, Gueguen R, Vincent-Viry M, Sass C, et al. Objectives, design and recruitment of a familial and longitudinal cohort for studying gene-environment interactions in the field of cardiovascular risk: the STANISLAS cohort. Clin Chem Lab Med 1998; 36:35–42.10.1515/CCLM.1998.007Search in Google Scholar PubMed

28 Mansour-Chemaly M, Haddy N, Siest G, Visvikis S. Family studies: their role in the evaluation of genetic cardiovascular risk factors. Clin Chem Lab Med 2002; 40:1085–119.10.1515/cclm.2002.190Search in Google Scholar

29 Vincent-Viry M, Schiele F, Gueguen R, Bohnet K, Visvikis S, Siest G. Biological variations and genetic reference values for apolipoprotein E serum concentrations: results from the STANISLAS cohort study. Clin Chem 1998; 44:957–65.10.1093/clinchem/44.5.957Search in Google Scholar

30 Tilly P, Sass C, Vincent-Viry M, Aguillon D, Siest G, Visvikis S. Biological and genetic determinants of serum apoC-III concentration: reference limits from the STANISLAS cohort. J Lipid Res 2003; 44:430–6.10.1194/jlr.M200006-JLR200Search in Google Scholar PubMed

31 Siest G, Henny J, Schiele F, editors. Références en biologie clinique. Collection OPTION BIO. Paris: Elsevier, 1990:679 pp.Search in Google Scholar

32 Pradhan AD, Cook NR, Buring JE, Manson JE, Ridker PM. C-Reactive protein is independently associated with fasting insulin in nondiabetic women. Arterioscler Thromb Vasc Biol 2003; 23:650–5.10.1161/01.ATV.0000065636.15310.9CSearch in Google Scholar PubMed

33 Golay A. Are postprandial triglyceride and insulin abnormalities neglected cardiovascular risk factors in type 2 diabetes? Eur J Clin Invest 2000; 30:12–8.10.1046/j.1365-2362.30.s2.3.xSearch in Google Scholar PubMed

34 Summers LK, Samra JS, Frayn KN. Impaired postprandial tissue regulation of blood flow in insulin resistance: a determinant of cardiovascular risk? Atherosclerosis 1999; 147:11–5.10.1016/S0021-9150(99)00172-0Search in Google Scholar

35 Isomaa B. A major health hazard: the metabolic syndrome. Life Sci 2003; 73:2395–411.10.1016/S0024-3205(03)00646-5Search in Google Scholar

36 Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, Bogardus C, et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 2002; 51:1889–95.10.2337/diabetes.51.6.1889Search in Google Scholar

37 Perry IJ, Wannamethee SG, Shaper AG. Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care 1998; 21:732–7.10.2337/diacare.21.5.732Search in Google Scholar

38 Whitfield JB, Zhu G, Nestler JE, Heath AC, Martin NG. Genetic covariation between serum gamma-glutamyltransferase activity and cardiovascular risk factors. Clin Chem 2002; 48:1426–31.10.1093/clinchem/48.9.1426Search in Google Scholar

39 Schiele F, Guilmin AM, Detienne H, Siest G. Gamma-glutamyltransferase activity in plasma: statistical distributions, individual variations and reference intervals. Clin Chem 1977; 23:1023–8.10.1093/clinchem/23.6.1023Search in Google Scholar

40 Zachrisson I, Wallensteen M, Dahlquist G. Determinants of blood glucose variability in adolescents with insulin-dependent diabetes mellitus. Acta Paediatr 1995; 84:70–4.10.1111/j.1651-2227.1995.tb13488.xSearch in Google Scholar

41 Chu NF, Spiegelman D, Hotamisligil GS, Rifai N, Stampfer M, Rimm EB. Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atherosclerosis 2001; 157:495–503.10.1016/S0021-9150(00)00755-3Search in Google Scholar

42 Kareinen A, Viitanen L, Halonen P, Lento S, Laakso M. Cardiovascular risk factors associated with insulin resistance cluster in families with early-onset coronary heart disease. Arterioscler Thromb Vasc Biol 2001; 21:1346–52.10.1161/hq0801.093655Search in Google Scholar PubMed

43 Agewall S. Insulin sensitivity and haemostatic factors in men at high and flow cardiovascular risk. J Intern Med 1999; 246:489–95.10.1046/j.1365-2796.1999.00543.xSearch in Google Scholar PubMed

44 Borggreve SE, De Vries R, Dullaart RP. Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin cholesterol acyltransferase and lipid transfer proteins. Eur J Clin Invest 2003; 33:1051–69.10.1111/j.1365-2362.2003.01263.xSearch in Google Scholar

45 Bach-Ngohou K, Ouguerram K, Nazih H, Maugere P, Ripolles-Piquer B, Zair Y, et al. Apolipoprotein E kinetics: influence of insulin resistance and type 2 diabetes. Int J Obes Relat Metab Disord 2002; 26:1451–8.10.1038/sj.ijo.0802149Search in Google Scholar

46 Shamir R, Shehadeh N, Rosenblat M, Eshasch-Adiv O, Coleman R, Kaplan M, et al. Oral insulin supplementation attenuates atherosclerosis progression in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2003; 23:104–10.10.1161/01.ATV.0000042232.42883.56Search in Google Scholar

47 Schiele F, Vincent-Viry M, Fournier B, Starck M, Siest G. Biological effects of eleven combined oral contraceptives on serum triglycerides, gamma-glutamyltransferase, alkaline phosphatase, bilirubin and other biochemical variables. Clin Chem Lab Med 1998; 36:871–8.10.1515/CCLM.1998.153Search in Google Scholar

48 Kasdorf G, Kalkhoff RK. Prospective studies of insulin sensitivity in normal women receiving oral contraceptive agents. J Clin Endocrinol Metab 1988; 66:846–52.10.1210/jcem-66-4-846Search in Google Scholar

49 Ferrannini E, Haffner SM, Stern MP. Essential hypertension: an insulin-resistant state. J Cardiovasc Pharmacol 1990; 15(Suppl 5):S18–25.10.1097/00005344-199000005-00004Search in Google Scholar

50 Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarette smoking. Lancet 1992; 339:1128–30.10.1016/0140-6736(92)90730-QSearch in Google Scholar

51 Hautanen A, Adlercreutz H. Hyperinsulinaemia, dyslipidaemia and exaggerated adrenal androgen response to adrenocorticotropin in male smokers. Diabetologia 1993; 36:1275–81.10.1007/BF00400805Search in Google Scholar

52 Ronnemaa T, Ronnemaa EM, Puukka P, Pyorala K, Laakso M. Smoking is independently associated with high plasma insulin levels in nondiabetic men. Diabetes Care 1996; 19:1229–32.10.2337/diacare.19.11.1229Search in Google Scholar

53 Leinonen E, Hurt-Camejo E, Wiklund O, Hulten LM, Hiukka A, Taskinen MR. Insulin resistance and adiposity correlate with acute phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis 2003; 166:387–94.10.1016/S0021-9150(02)00371-4Search in Google Scholar

54 Chen W, Srinivasan SR, Elkasabany A, Berenson GS. The association of cardiovascular risk factor clustering related to insulin resistance syndrome (Syndrome X) between young parents and their offspring: the Bogalusa Heart Study. Atherosclerosis 1999; 145:197–205.10.1016/S0021-9150(99)00025-8Search in Google Scholar

55 Allard P, Delvin EE, Paradis G, Hanley JA, O’Loughlin J, Lavalle C, et al. Distribution of fasting plasma insulin, free fatty acids, and glucose concentrations and of homeostasis model assessment of insulin resistance in a representative sample of Quebec children and adolescents. Clin Chem 2003; 49:644–9.10.1373/49.4.644Search in Google Scholar PubMed

56 Gallois Y, Vol S, Cacès E, Balkau B and the DESIR Study Group. Distribution of fasting serum insulin measured by enzyme immunoassay in an unselected population of 4032 individuals. Reference values according to age and sex. Diabetes Metab 1996; 22:427–31.Search in Google Scholar

57 Robbins DC, Andersen L, Bowsher R, Chance R, Dinesen B, Frank B, et al. Report of the American Diabetes Association’s task force on standardization of the insulin assay. Diabetes 1996; 45:242–56.10.2337/diab.45.2.242Search in Google Scholar PubMed